STAT+: Roivant immune drug significantly outperformed placebo in treating rare skin disease
Stat News • 2/6/2026
Summary
Roivant's immune drug significantly outperformed placebo in a small trial aimed at treating a rare skin disease. The drug was effective in clearing lesions associated with the condition.
Advertisement
Lindy Score Breakdown (V4.2)
11d
Age
1
Sources
from cluster
269
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier2% (0.5^269/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^269/48 = 0.020558) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 11 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: As China’s drug industry races ahead, its GLP-1 race is accelerating too
Stat News • Today
STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials
Stat News • Today
STAT+: Ocular’s experimental eye drug beats low dose of Regeneron’s Eylea in late-stage trial
Stat News • Today
STAT+: In a financial pinch, major health insurers are turning to AI for help
Stat News • Today
STAT+: Does Medicare’s ACCESS model pay enough?
Stat News • Today
STAT+: Exit of CDC’s acting director highlights agency’s lack of leader
Stat News • 2 days ago
STAT+: Kennedy says he’ll act on legal challenge to ultra-processed foods
Stat News • 1 day ago
STAT+: Medicare Advantage growth dwindles for a second straight year
Stat News • 1 day ago
STAT+: Breakup between Brigham and Dana-Farber is getting messier fast
Stat News • 1 day ago
STAT+: Psilocybin data could be good enough for approval
Stat News • Today
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and more
Stat News • 5 days ago
STAT+: Prasad overruled FDA staff to reject Moderna’s flu vaccine application
Stat News • 6 days ago
STAT+: FDA refuses to review Moderna’s influenza vaccine
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about FDA rejecting a Moderna vaccine, compounding in the crosshairs and more
Stat News • 6 days ago
STAT+: A change at the top of Sanofi
Stat News • 5 days ago
STAT+: The unusual Prasad missive in the FDA’s rejection of the Moderna flu shot application
Stat News • 6 days ago
STAT+: Pediatricians confront HHS in vaccine showdown
Stat News • 4 days ago